Megan West

Megan West is a Managing Director at Avalere. She advises on policy and market-based strategies related to drug pricing, cell and gene therapy development value-based contracting, and innovative approaches to patient access. She has helped life sciences companies assess how Inflation Reduction Act drug pricing reforms will impact business, convening stakeholders across functional therapeutic areas to execute strategies spanning from drug discovery and early development through to commercialization.